本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

武田制药

15.38
+0.06000.39%
盘后15.410.0300+0.20%19:56 EDT
成交量:122.88万
成交额:1,888.79万
市值:485.44亿
市盈率:37.15
高:15.43
开:15.40
低:15.34
收:15.32
数据加载中...
2022/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/14

超过5%披露

TAKEDA PHARMACEUTICAL CO LTD
2021/09/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals